Mayo Clinic
EchoGo Heart Failure, developed in partnership with the Mayo Clinic, helps physicians detect heart failure with preserved ejection fraction.
NeuTrace focused on developing in-procedure AI tools for electrophysiology.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
The partnership will focus on software that uses ECGs to find left ventricular dysfunction and atherosclerotic cardiovascular disease.
This week's top stories include the Mayo Clinic no longer scheduling appointments for patients in most Medicare Advantage plans, and an Oklahoma City hospital's security response after COVID-19-related social media posts accused providers of murder.
HIMSS22
The Mayo Clinic's Muhammad Babur discusses the potential, ethics and challenges of using AI in healthcare.
The new effort will focus on cardiometabolic conditions in order to give clinicians more insights into patient care.
This week's top stories include use of the J&J vaccine being halted due to rare, severe reactions, the Mayo Clinic launching a remote diagnostics platform, and an Omada tool that helps physical therapists virtually measure a patient's movement.
Also: Vocalis Health and Mayo Clinic seek new pulmonary hypertension biomarkers; Sensyne Health and Microsoft's strategic partnership focuses on clinical AI co-development.
Also: Google reportedly coming to terms with European Commission on Fitbit deal; Eko and 3M's digital stethoscope.